bio-logo-footer.png
Blake Insomnia Therapeutics Inc. Announces Submitting Clinical Trial Application for Phase II Clinical Testing
25 août 2017 09h30 HE | Blake Insomnia Therapeutics, Inc.
NEW YORK, Aug. 25, 2017 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics Inc. (OTCQB:BKIT), a New York based pharmaceutical company devoted to improving quality of life for people with insomnia, is...
bio-logo-footer.png
Blake Insomnia Therapeutics Inc. Announces Appointment of Dr. Eric Leire to its Board of Directors
09 mai 2017 13h20 HE | Blake Insomnia Therapeutics, Inc.
NEW YORK, May 09, 2017 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics Inc. (OTCQB:BKIT) a New York based pharmaceutical company is pleased to announce the appointment of Dr. Eric Leire to join CEO...
bio-logo-footer.png
Blake Insomnia Therapeutics Inc. Closes Joint Venture with Sajo Consulting LLC
24 févr. 2017 20h08 HE | Blake Insomnia Therapeutics, Inc.
NEW YORK, Feb. 25, 2017 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics Inc. (OTCQB:BKIT) and Sajo Consulting LLC are pleased to announce completion of a joint venture agreement for the development...
bio-logo-footer.png
Blake Insomnia Therapeutics Inc. Seeks Financing for Clinical Trials
17 janv. 2017 08h30 HE | Blake Insomnia Therapeutics, Inc.
NEW YORK, Jan. 17, 2017 (GLOBE NEWSWIRE) -- Blake Insomnia Therapeutics Inc. (OTC:BKIT) is preparing to launch a fundraising drive to complete Phase II clinical testing of its patent-pending ZLX-1...